1 recruiting. .
Follow Guohui Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients Sintilimab Injection - Immune Related Adverse Events, PD-1 | Recruiting | Guohui Li | 100 | 2021-02-26 | 2024-12-27 |
sintilimab (1)
China (1)